SCHEMBL31694500

CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O

nearest known ligand 0.68

Predicted protein targets (top 9)

	gene	UniProt	supporting neighbours	confidence
▸	NPY2R	P49146	8/20	0.66

▸	NPY4R	P50391	8/20	0.66

▸	NPY5R	Q15761	8/20	0.66

▸	NPY1R	P25929	6/20	0.66

▸	NMUR2	Q9GZQ4	5/20	0.60

▸	NMUR1	Q9HB89	5/20	0.60

▸	TFPI	P10646	3/20	0.58

▸	EP300	Q09472	1/20	0.58

▸	HIF1A	Q16665	1/20	0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29357881	0.93	NTSR1 (0.65)	NPY1R
SCHEMBL31182982	0.90	NPY2R (0.73)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL29855986	0.90	NPY2R (0.66)	NPY2RNPY4RNPY5RNPY1RNMUR2
SCHEMBL30607363	0.90	NPY2R (0.66)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL30658393	0.89	NPY2R (0.68)	NPY2RNPY4RNPY5RNPY1RNMUR2
Oncocin SCHEMBL29538886	0.89	KDM1A (0.62)	NPY2RNPY4RNPY5RNPY1R
SCHEMBL30495647	0.89	NPY2R (0.77)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL11150031	0.89	NPY2R (0.73)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL31146614	0.88	NPY2R (0.73)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL30320527	0.88	NPY2R (0.65)	NPY2RNPY4RNPY5RNPY1RNMUR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-RE50618-E1	Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same	PHARMAIN CORPORATION (US)	2025-10-07	—	—	US	disclosed